Gary Patou

CIK 1283535 · View on SEC EDGAR ↗

Insider

First SEC filing: June 8, 2026 · Latest: June 8, 2026

On this page

Insider at

Insider transactions

0 buys (P) 1 sells (S) Net: $-70,251 + 82 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

82 other filings hidden
Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
June 5, 2026 XENE S 10b5-1 1,322 $53.14 $70,251 24,896 Direct -5.04% Disposed 18.4% (price as of 2026-08-18)
Nov. 22, 2024 XENE S 2,040 $41.05 $83,742 23,573 Direct -7.96% Disposed 53.3% (price as of 2026-08-18)
Nov. 22, 2024 XENE S 2,851 $41.11 $117,205 23,573 Direct -10.79% Disposed 53.0% (price as of 2026-08-18)
Dec. 14, 2023 XENE S 7,598 $41.05 $311,898 4,902 Indirect -60.78% Disposed 53.3% (price as of 2026-08-18)
Dec. 13, 2023 XENE S 7,598 $41.05 $311,898 4,902 Indirect -60.78% Disposed 53.3% (price as of 2026-08-18)
Dec. 13, 2023 XENE S 3,977 $39.84 $158,444 23,573 Direct -14.44% Disposed 57.9% (price as of 2026-08-18)
Dec. 13, 2023 XENE S 2,303 $39.10 $90,047 23,573 Direct -8.90% Disposed 60.9% (price as of 2026-08-18)
Dec. 13, 2023 XENE S 5,100 $38.94 $198,594 23,573 Direct -17.79% Disposed 61.6% (price as of 2026-08-18)
Nov. 25, 2022 XENE S 1,937 $34.79 $67,388 23,573 Direct -7.59% Disposed 80.8% (price as of 2026-08-18)
Nov. 23, 2022 XENE S 2,057 $34.33 $70,617 23,573 Direct -8.03% Disposed 83.3% (price as of 2026-08-18)
Aug. 10, 2017 XENE P 7,500 $2.78 $20,850 12,500 Indirect +150.00% Acquired 2162.9% (price as of 2026-08-18)
Aug. 8, 2017 XENE P 5,000 $3.00 $15,000 5,000 Indirect — Acquired 1997.0% (price as of 2026-08-18)
Aug. 7, 2014 PCRX S 10b5-1 20,000 $100.26 $2,005,200 0 Direct -100.00% Disposed -76.6% (price as of 2026-08-18)
July 14, 2014 PCRX S 10b5-1 2,107 $87.58 $184,531 0 Direct -100.00% Disposed -73.2% (price as of 2026-08-18)
July 14, 2014 PCRX S 10b5-1 27,593 $86.91 $2,398,108 2,407 Direct -91.98% Disposed -73.0% (price as of 2026-08-18)
May 12, 2014 PCRX S 10b5-1 10,000 $75.00 $750,000 0 Direct -100.00% Disposed -68.7% (price as of 2026-08-18)
May 9, 2014 PCRX S 10b5-1 20,000 $74.08 $1,481,600 0 Direct -100.00% Disposed -68.3% (price as of 2026-08-18)
Oct. 1, 2013 PCRX S 10b5-1 20,000 $48.92 $978,400 0 Direct -100.00% Disposed -52.0% (price as of 2026-08-18)

Showing latest 100 of 114 transactions

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
June 3, 2026 XENE Restricted Share Units Common Shares (1,593) $0.00 — 1,593 Acquired
June 3, 2026 XENE Share Option (Right to Buy) Common Shares (10,507) $53.46 June 2, 2036 10,507 Acquired
June 1, 2026 XENE Restricted Share Units Common Shares (2,645) — — 2,645 Disposed
June 5, 2025 XENE Restricted Share Units Common Shares (2,645) $0.00 — 2,645 Acquired
June 5, 2025 XENE Share Option (Right to Buy) Common Shares (17,012) $30.73 June 4, 2035 17,012 Acquired
Nov. 22, 2024 XENE Stock Option (Right to Buy) Common Shares (3,086) $13.48 May 3, 2025 3,086 Disposed
Nov. 22, 2024 XENE Stock Option (Right to Buy) Common Shares (3,500) $7.38 June 1, 2026 3,500 Disposed
June 5, 2024 XENE Stock Option (Right to Buy) Common Shares (15,542) $38.16 June 4, 2034 15,542 Acquired
Dec. 13, 2023 XENE Stock Option (Right to Buy) Common Shares (5,144) $9.00 Nov. 3, 2024 5,144 Disposed
Dec. 13, 2023 XENE Stock Option (Right to Buy) Common Shares (2,800) — Jan. 13, 2024 2,800 Disposed
Dec. 13, 2023 XENE Stock Option (Right to Buy) Common Shares (6,378) — Jan. 13, 2024 6,378 Disposed
June 2, 2023 XENE Stock Option (Right to Buy) Common Shares (18,475) $38.96 June 1, 2033 18,475 Acquired
Nov. 25, 2022 XENE Stock Option (Right to Buy) Common Shares (2,057) — Dec. 31, 2022 2,057 Disposed
June 28, 2022 XENE Stock Option (Right to Buy) Common Shares (18,000) $30.11 June 27, 2032 18,000 Acquired
Dec. 8, 2021 XENE Stock Option (Right to Buy) Common Shares (2,057) — Dec. 31, 2021 2,057 Disposed
June 3, 2021 XENE Stock Option (Right to Buy) Common Shares (10,000) $18.56 June 2, 2031 10,000 Acquired
Oct. 28, 2020 XENE Stock Option (Right to Buy) Common Shares (2,057) — Dec. 31, 2020 2,057 Disposed
June 1, 2020 XENE Stock Option (Right to Buy) Common Shares (10,000) $13.11 May 31, 2030 10,000 Acquired
Dec. 4, 2019 XENE Stock Option (Right to Buy) Common Shares (2,057) — Dec. 31, 2019 2,057 Disposed
Sept. 16, 2019 XENE Stock Option (Right to Buy) Common Shares (15,000) $9.44 Sept. 15, 2029 15,000 Acquired
Dec. 14, 2018 XENE Stock Option (Right to Buy) Common Shares (2,057) — Dec. 31, 2018 2,057 Disposed
June 14, 2018 XENE Stock Option (Right to Buy) Common Shares (8,230) — June 26, 2018 8,230 Disposed
June 4, 2018 XENE Stock Option (Right to Buy) Common Shares (15,000) $6.20 June 3, 2028 15,000 Acquired
June 1, 2017 XENE Stock Option (Right to Buy) Common Shares (3,500) $3.85 May 31, 2027 3,500 Acquired
Dec. 6, 2016 XENE Stock Option (Right to Buy) Common Shares (12,345) — Dec. 31, 2016 12,345 Disposed
June 2, 2016 XENE Stock Option (Right to Buy) Common Shares (3,500) $7.38 June 1, 2026 3,500 Acquired
Nov. 4, 2015 XENE Stock Option (Right to Buy) Common Shares (3,497) — Dec. 31, 2015 3,497 Disposed
May 4, 2015 XENE Stock Option (Right to Buy) Common Shares (3,086) — May 3, 2025 3,086 Acquired
Jan. 7, 2015 XENE Stock Option (Right to Buy) Common Shares (3,497) — May 8, 2015 3,497 Disposed
Aug. 7, 2014 PCRX Stock Option (Right to Buy) Common Stock (3,524) $11.68 June 7, 2022 3,524 Disposed
Aug. 7, 2014 PCRX Stock Option (Right to Buy) Common Stock (14,364) $10.81 June 5, 2022 14,364 Disposed
Aug. 7, 2014 PCRX Stock Option (Right to Buy) Common Stock (882) $5.49 Dec. 29, 2020 882 Disposed
Aug. 7, 2014 PCRX Stock Option (Right to Buy) Common Stock (1,230) $1.61 Sept. 2, 2020 1,230 Disposed
July 14, 2014 PCRX Stock Option (Right to Buy) Common Stock (7,303) $10.81 June 5, 2022 7,303 Disposed
July 14, 2014 PCRX Stock Option (Right to Buy) Common Stock (20,237) $5.49 Dec. 29, 2020 20,237 Disposed
July 14, 2014 PCRX Stock Option (Right to Buy) Common Stock (2,460) $1.61 Sept. 2, 2020 2,460 Disposed
June 3, 2014 PCRX Stock Option (Right to Buy) Common Stock (25,000) $81.00 June 2, 2024 25,000 Acquired
May 12, 2014 PCRX Stock Option (Right to Buy) Common Stock (10,000) $5.49 Dec. 29, 2020 10,000 Disposed
May 9, 2014 PCRX Stock Option (Right to Buy) Common Stock (6,836) $5.49 Dec. 29, 2020 6,836 Disposed
May 9, 2014 PCRX Stock Option (Right to Buy) Common Stock (13,164) $1.61 Sept. 2, 2020 13,164 Disposed
Oct. 1, 2013 PCRX Stock Option (Right to Buy) Common Stock (20,000) $1.61 Sept. 2, 2020 20,000 Disposed
July 2, 2013 PCRX Stock Option (Right to Buy) Common Stock (10,000) $1.61 Sept. 2, 2020 10,000 Disposed
July 1, 2013 PCRX Stock Option (Right to Buy) Common Stock (10,958) $1.61 Sept. 2, 2020 10,958 Disposed
July 1, 2013 PCRX Stock Option (Right to Buy) Common Stock (19,042) $1.61 Sept. 2, 2020 19,042 Disposed
April 12, 2013 PCRX Stock Option (Right to Buy) Common Stock (10,000) $1.61 Sept. 2, 2020 10,000 Acquired
April 1, 2013 PCRX Stock Option (Right to Buy) Common Stock (30,000) $1.61 Sept. 2, 2020 30,000 Acquired
June 7, 2012 PCRX Stock Option (Right to Buy) Common Stock (60,000) $11.68 June 7, 2022 60,000 Acquired
June 5, 2012 PCRX Stock Option (Right to Buy) Common Stock (40,000) $10.81 June 5, 2022 40,000 Acquired
June 5, 2012 PCRX Director Stock Option (Right to Buy) Common Stock (40,000) $10.81 June 5, 2022 40,000 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 15 holdings

Securities held when first becoming an insider, per SEC Form 3.

Date Ticker Security Shares Ownership
Nov. 4, 2014 XENE Stock Option (Right to Buy)→ Common Shares — Direct
Nov. 4, 2014 XENE Stock Option (Right to Buy)→ Common Shares — Direct
Nov. 4, 2014 XENE Stock Option (Right to Buy)→ Common Shares — Direct
Nov. 4, 2014 XENE Stock Option (Right to Buy)→ Common Shares — Direct
Nov. 4, 2014 XENE Stock Option (Right to Buy)→ Common Shares — Direct
Nov. 4, 2014 XENE Stock Option (Right to Buy)→ Common Shares — Direct
Nov. 4, 2014 XENE Stock Option (Right to Buy)→ Common Shares — Direct
Nov. 4, 2014 XENE Stock Option (Right to Buy)→ Common Shares — Direct
Nov. 4, 2014 XENE Stock Option (Right to Buy)→ Common Shares — Direct
Nov. 4, 2014 XENE Stock Option (Right to Buy)→ Common Shares — Direct
Nov. 4, 2014 XENE Stock Option (Right to Buy)→ Common Shares — Direct
Nov. 4, 2014 XENE Stock Option (Right to Buy)→ Common Shares — Direct
Feb. 2, 2011 PCRX Stock Option (Right to Buy)→ Common Stock (59,042) 59,042 Direct
Feb. 2, 2011 PCRX Stock Option (Right to Buy)→ Common Stock (59,042) 59,042 Direct
Feb. 2, 2011 PCRX Stock Option (Right to Buy)→ Common Stock (42,368) 42,368 Direct

Compensation (DEF 14A)

Matched by name from proxy statements (DEF 14A) — verify against the filing.

PCRX

Fiscal year Salary Bonus Stock awards Option awards Non-equity incentive Pension change Other Total
2014 $317,600 $90,000 — $1,477,443 — — — $1,885,043
2013 $317,600 $50,000 — — — — — $367,600
2011 $317,604 $100,000 — — — — $19,056 $436,660

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.